Navigation Links
Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
Date:4/18/2008

IRVINE, Calif., April 18 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced that yesterday the first patients were treated in a United States feasibility study using the Edwards SAPIEN transcatheter heart valve in addressing a congenital condition in which the valve between the right ventricle and the pulmonary artery is nonfunctional.

"We were able to successfully implant the Edwards SAPIEN transcatheter heart valve percutaneously in the first three patients treated in this trial. All of the patients are recovering and are expected to go home today," said Ziyad M. Hijazi, M.D., M.P.H., director of the Rush Center for Congenital and Structural Heart Disease, chief of the section of pediatric cardiology and professor in the departments of pediatrics and internal medicine at Rush University, Chicago, and a paid consultant to Edwards Lifesciences. "Patients with congenital right ventricular outflow tract problems typically face the burden of multiple open-heart surgeries throughout their lives, either to replace their 'native' diseased valves or, as they age, their bioprosthetic replacement valves. This clinical study will enable physicians to offer a minimally-invasive alternative to symptomatic patients with a failing pulmonary valve conduit, giving them the opportunity to recover and resume their normal activities."

The U.S. Food and Drug Administration (FDA) conditionally approved the investigational device exemption (IDE) clinical trial in late 2007. The study of 30 patients at three hospitals will enable the collection of safety and effectiveness data, ultimately in support of a commercial approval application.

In this transcatheter valve
'/>"/>

SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
2. Aida Announces New Anti-Cancer Drug Under Development
3. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
4. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
5. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
6. ViroPharma Announces Discontinuation of HCV-796 Development
7. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
8. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
9. Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinsons Disease
10. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
11. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... opportune time to find the best plan at the ... Through the end of the year, thousands ... about their health coverage. This is when the ... benefits they will sign up and pay for in ... part of this decision, says Independent Retail Pharmacist Steve ...
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Manufacturing Industry in the U.S. and ... ,, http://www.reportlinker.com/p0167745/Surgical-and-Medical-Instrument-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, ... Surgical and Medical Instrument Manufacturing Industry ...
(Date:12/15/2009)... Dec. 15 Waters Corporation (NYSE: ... Publisher(TM) (v.7.1 SR4), an electronic laboratory notebook solution ... a secure electronic repository that stores and manages ... database and is used to boost efficiency in ... the SAFE-BioPharma digital identity and signature standard. The ...
Breaking Medicine Technology:Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hema 6741 1Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hema 6741 2BIO key 28R 29 Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 10989 1BIO key 28R 29 Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 10989 2BIO key 28R 29 Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 10989 3Mario Badescu 26apos 3Bs Acne Spot Treatment Picked as ELLE Readers 26apos 3B Favorite 62569 1
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today ... on anti-arrhythmia data from the MERLIN,TIMI-36 study, have ... Cardiology (ESC) Congress 2007 taking place in Vienna, ... update session entitled, The Effect of Ranolazine, a,Novel ...
... Genetic testing can be,used to help personalize the ... research published in the,September 1, 2007, issue of ... This result represents one of the first applications ... medical care., Because individuals metabolize drugs differently, ...
Other Medicine Technology:CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 2CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 3Genetics Determine Optimal Drug Dose of Common Anticoagulant 2Genetics Determine Optimal Drug Dose of Common Anticoagulant 3
(Date:12/15/2009)... help, experts say , , TUESDAY, Dec. 15 (HealthDay News) ... how to spot the signs of stroke in relatives ... , Emergency medical treatment within three hours of the ... damage and lead to better recovery. , The Kids ... graders in Texas who were divided into two groups. ...
(Date:12/15/2009)... that phthalates actually cause the condition, experts ... Common chemicals found in plastic toys and elsewhere ... in boys, preliminary research suggests. , The ... pediatricians, adds fuel to the debate over these ... by some scientists. The chemical industry claims the ...
(Date:12/15/2009)... of secure USB devices, today launches SafeConsole 4.0, the web ... software is designed to provide better usability for employees and ... and range of licensing options. , ... ... www.blockmastersecurity.com ) a leading provider of secure USB devices, today ...
(Date:12/15/2009)... within a week of getting news, researchers say ... stress can put newly diagnosed prostate cancer patients ... a new study has found. , Researchers analyzed ... cancer between 1961 and 2004. Of those men, ... a year of cancer diagnosis and 136 (0.08 ...
(Date:12/15/2009)... proud to announce the addition of David Tokofsky to ... Director of Development in the State of California and ... ,, David Tokofsky was elected to the Los ... 1995. As the Board Member for District Five, he ... Los Angeles through East Los Angeles to the Southeast ...
Breaking Medicine News(10 mins):Health News:Boosting Kids' Stroke IQ May Save Lives 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 2Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 3Health News:Accelify Announces the Addition of David Tokofsky to its National Board of Advisors 2
... Effort is Launched With UC Davis Collaboration, ... KOOL ), a leading supplier of innovative ... cells for treatment of disease,and injury, today announced ... The Company has created a wholly-owned subsidiary, Vantus, ...
... toward personalized medicine, experts say , , WEDNESDAY, Feb. 6 (HealthDay ... could help a small minority of HIV patients discover whether ... cause serious side effects. , The test detects sensitivity to ... genetic makeup is linked to poor reactions to the medicine. ...
... risk factors at once, , , WEDNESDAY, Feb. 6 (HealthDay News) ... signs of some kidney damage may be able to significantly ... at once. , That,s the conclusion of a new ... New England Journal of Medicine , that found intensive ...
... Burnham Institute for Medical Research (Burnham Institute) have provided ... a suppressor role in skin cancer development. ATF2 ... the first step in the translation of genetic code, ... and ionizing radiation. This function of ATF2 in ...
... - The Vilcek Foundation has announced the names of the ... the arts. Dr. Inder Verma is the prize recipient ... composer Osvaldo Golijov. The Vilcek Foundation Prizes are awarded ... the United States. , In explaining the motivation ...
... Montefiore, NEW YORK, Feb. 6 Elephant Ensemble ... of a Brave Little,Girl to the Bronx when they ... Medical Center., This represents Elephant,s mission to bring ... hospitals who do not have significant,programming., Elephant Ensemble ...
Other Medicine News:Health News:Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine 2Health News:Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine 3Health News:Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine 4Health News:Test Detects Sensitivity to HIV Drug 2Health News:Aggressive Diabetes Therapy Lowers Death Risk, Study Finds 2Health News:Aggressive Diabetes Therapy Lowers Death Risk, Study Finds 3Health News:Gene found to play a suppressor role in skin cancer development 2Health News:Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science 2
When You Need Optimal Patient Comfort with Minimal Weight at a Nonunion Site...Demand The OrthoPak Noninvasive Bone Growth Stimulator., ,Most Appropriate for the Proximal Femur, Metatarsal/Tarsal...
... its new multifunctional lithotripsy system Lithoskop. ... data management is the perfect symbiosis ... Lithoskop is an engineering masterpiece for ... applications like lithotripsy, endourology, urodiagnostics, percutaneous ...
... stimulator for the treatment of long bone ... stimulator is a useful adjunct for the ... planned or when patient compliance may be ... surgically implanted, patients are assured of therapeutic ...
... cataract surgery following refractive surgery grows larger ... for surgeons, as calculating IOL power for ... power following RK, ALK, PRK and LASIK ... or topography. For example, keratometry and simulated ...
Medicine Products: